Crescenta Fertility Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 30-12-2024
- Paid Up Capital ₹ 8.70 M
as on 30-12-2024
- Company Age 7 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 2.53 M
as on 30-12-2024
- Revenue %
(FY 2022)
- Profit 15.83%
(FY 2022)
- Ebitda
- Net Worth -95.36%
(FY 2022)
- Total Assets -9.43%
(FY 2022)
About Crescenta Fertility
The Company is engaged in the Veterinary Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 8.70 M.
The company has closed loans amounting to ₹2.53 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Abha Barik, Mitanjali Sethy, Benudhar Pande, and Two other members serve as directors at the Company.
- CIN/LLPIN
U85200OR2017PTC026937
- Company No.
026937
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 Apr 2017
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Cuttack
Industry
Company Details
- Location
Khorda, Odisha, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Crescenta Fertility?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Abha Barik  | Director | 25-Apr-2017 | Current |
| Mitanjali Sethy | Director | 02-Dec-2024 | Current |
| Benudhar Pande | Director | 20-Jun-2024 | Current |
| Prasant Behera | Director | 25-Apr-2017 | Current |
| Nihar Bhoi | Director | 02-Dec-2024 | Current |
Financial Performance of Crescenta Fertility.
Shushruta Institute For Medical Science Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 15.83% increase in profit. The company's net worth observed a substantial decline by a decrease of 95.36%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Crescenta Fertility?
Unlock access to Crescenta Fertility's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Samaleswari Multispeciality Hospital Private LimitedActive 3 years 5 monthsBenudhar Pande is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 18 Oct 2017 | ₹2.53 M | Satisfied |
How Many Employees Work at Crescenta Fertility?
Unlock and access historical data on people associated with Crescenta Fertility, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Crescenta Fertility, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Crescenta Fertility's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
